Global Companion Animal Ear Infection Treatment Market (2021 to 2026) - by Disease Type, Mode of Operation, Product, Animal Type and Region

DUBLIN, March 1, 2022 /PRNewswire/ -- The "Companion Animal Ear Infection Treatment Market Research Report by Disease Type, by Mode of Operation, by Product, by Animal Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Companion Animal Ear Infection Treatment Market size was estimated at USD 532.10 million in 2020, is expected to reach USD 569.98 million in 2021, and is projected to grow at a CAGR of 7.45% to reach USD 819.28 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Companion Animal Ear Infection Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:

• Based on Disease Type, the market was studied across Otitis Externa, Otitis Interna, and Otitis Media.
• Based on Mode of Operation, the market was studied across Oral and Topical.
• Based on Product, the market was studied across Aminoglycosides, Anti-bacterial, Anti-fungal, Corticosteroids, and Fluoroquinolones.
• Based on Animal Type, the market was studied across Cats and Dogs.
• Based on Region, the market was studied across the Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Companion Animal Ear Infection Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Companion Animal Ear Infection Treatment Market, including Calder Vets Ltd., Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Merck & Co., Inc., Penn Veterinary Supply, Inc., Piedmont Animal Health, Inc., VCA Inc., Vedco, Inc., Vetoquinol S.A., Vetruus Ltd., Virbac S.A., Wedgewood Village Pharmacy, LLC, and Zoetis Inc..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Companion Animal Ear Infection Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Companion Animal Ear Infection Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Companion Animal Ear Infection Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Companion Animal Ear Infection Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Companion Animal Ear Infection Treatment Market?
6. What is the market share of the leading vendors in the Global Companion Animal Ear Infection Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Companion Animal Ear Infection Treatment Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Number of Pet Owners and Awareness About Animal Hygiene
5.1.1.2. Growing Incidences of Ear Diseases in Pets Associated with a Bacterial Infection
5.1.1.3. Protection of Humans Against Zoonotic
5.1.2. Restraints
5.1.2.1. High Cost of Purchasing and Maintaining the Equipment
5.1.3. Opportunities
5.1.3.1. New Enhancements and Advancements in the Animal Ear Infection Treatments
5.1.3.2. Strategic Collaborations Along with Emergence of Market Players Across the Developing Economies
5.1.4. Challenges
5.1.4.1. Complications after Several Treatments of Ear Infection
5.2. Cumulative Impact of COVID-19

6. Companion Animal Ear Infection Treatment Market, by Disease Type
6.1. Introduction
6.2. Otitis Externa
6.3. Otitis Interna
6.4. Otitis Media

7. Companion Animal Ear Infection Treatment Market, by Mode of Operation
7.1. Introduction
7.2. Oral
7.3. Topical

8. Companion Animal Ear Infection Treatment Market, by Product
8.1. Introduction
8.2. Aminoglycosides
8.3. Anti-bacterial
8.4. Anti-fungal
8.5. Corticosteroids
8.6. Fluoroquinolones

9. Companion Animal Ear Infection Treatment Market, by Animal Type
9.1. Introduction
9.2. Cats
9.3. Dogs

10. Americas Companion Animal Ear Infection Treatment Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Companion Animal Ear Infection Treatment Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand

12. Europe, Middle East & Africa Companion Animal Ear Infection Treatment Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Calder Vets Ltd.
14.2. Ceva Sante Animale
14.3. Dechra Pharmaceuticals PLC
14.4. Elanco Animal Health Incorporated
14.5. Merck & Co., Inc.
14.6. Penn Veterinary Supply, Inc.
14.7. Piedmont Animal Health, Inc.
14.8. VCA Inc.
14.9. Vedco, Inc.
14.10. Vetoquinol S.A.
14.11. Vetruus Ltd.
14.12. Virbac S.A.
14.13. Wedgewood Village Pharmacy, LLC
14.14. Zoetis Inc.

15. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/9wehan

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets